Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Lifecare AS ( (DE:LFC0) ) has shared an announcement.
Lifecare ASA has successfully tested a new chemistry with improved sensitivity in their CGM sensors, which could significantly enhance sensor performance by improving the signal-to-noise ratio and simplifying data processing. This development marks a potential advance in glucose monitoring technology, promising better outcomes for patients with diabetes as ongoing tests continue to validate these improvements.
More about Lifecare AS
Lifecare ASA is a clinical stage medical sensor company focused on developing next-generation Continuous Glucose Monitoring (CGM) systems. Utilizing osmotic pressure and Nano-granular Tunnelling Resistive sensor technology, Lifecare aims to enhance sensing and monitoring of various body analytes, providing solutions for both humans and pets.
YTD Price Performance: -0.40%
Average Trading Volume: 333
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €16.75M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.
